Dadtum, Jovie .
HRN: 09-13-66 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/24/2022
CEFUROXIME 1.5GM (VIAL)
05/24/2022
05/26/2022
IV
2 Doses
Q8
S/P CS
Waiting Final Action
05/25/2022
CEFUROXIME 500MG (TAB)
05/25/2022
06/01/2022
ORAL
500mg
Q12
S/P LTCS
Waiting Final Action